Cargando…
Pei regimen: a therapeutic option in small cell lung cancer? A retrospective monoinstitutional analysis of 46 consecutive cases
OBJECTIVES: Combination chemotherapy is very active in small cell lung cancer (SCLC), although no improvement in overall survival (OS) has been done in the last 25 years, with Cisplatin-Etoposide (PE) still considered the world-wide standard, with an average median survival of about 7–8 months in pa...
Autores principales: | Boni, Corrado, Pagano, Maria, Baldi, Licia, Gnoni, Roberta, Braglia, Luca, Savoldi, Luisa, Zanelli, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427968/ https://www.ncbi.nlm.nih.gov/pubmed/25903963 http://dx.doi.org/10.1186/s12967-015-0491-3 |
Ejemplares similares
-
The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience
por: Lombardi, Giuseppe, et al.
Publicado: (2014) -
PO-1456 Impact of COVID-19 pandemic to radiotherapy activities: a monoinstitutional evaluation
por: Patani, F., et al.
Publicado: (2021) -
FDG-PET/CT in the Radiotherapy Treatment Planning of Locally Advanced Anal Cancer: A Monoinstitutional Experience
por: Di Carlo, Clelia, et al.
Publicado: (2021) -
Monoinstitutional real world experience in management of Vinflunine as second line therapy for transitional cell carcinoma of the urothelium
por: Schinzari, Giovanni, et al.
Publicado: (2018) -
Ipilimumab and Stereotactic Radiosurgery with CyberKnife(®) System in Melanoma Brain Metastases: A Retrospective Monoinstitutional Experience
por: Borzillo, Valentina, et al.
Publicado: (2021)